Shubham Singh - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Shubham Singh's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Shubham Singh

Shubham Singh

Verified

Business Journalist, Business Today (India)

Delhi

Biography

An ambitious and hardworking individual who always likes taking up challenging roles to showcase his skills in the media industry.

Final Covers

financial regulation, banking financial services, fintech insurance, economyinvestment funds, finance Luxembourg, euro zone

Journalist Type

-

Seniority Positions

-

Medium Formats

-

Content

Total articles 2213

  • J&J Survey: Clinician Burnout And Aging Populations Drive Demand For AI And Robotics In Future Health Care

    By Shubham Singh Verified| Citeline Verified J&J Survey: Clinician Burnout And Aging Populations Drive Demand For AI And Robotics In Future Health CareA Global Pulse Check Finds Optimism In AI, Robotics And Data-Driven Solutions For Aging Care. According to a survey of health care professionals by J&J, over 45% of surveyed respondents reported experiencing symptoms of burnout, including emotional exhaustion and reduced sense of personal accomplishment. This affects not just clinicians, but also the quality and safety of care they deliver.

    By Shubham Singh Verified · Citeline

    Apr. 18, 2025

  • Indian Medtechs Call US Tariffs A Challenge To Growth And Seek Reciprocal Regulatory Access

    By Shubham Singh Verified| Citeline Verified Indian Medtechs Call US Tariffs A Challenge To Growth And Seek Reciprocal Regulatory AccessIndian Medtech Firms Urge US To Level The Playing Field With Fair Tariffs And Reciprocal Regulatory AccessIndia’s medical technology industry is raising the alarm over steep new US tariffs on imported medical devices. It argues for structural change to address “unequal regulatory access” and non-tariff barriers.

    By Shubham Singh Verified · Citeline

    Apr. 16, 2025

  • J&J Medtech’s FDA-Cleared DUALTO System Prepares For Future Use With OTTAVA Robotic Platform

    By Shubham Singh Verified| Citeline Verified J&J Medtech’s FDA-Cleared DUALTO System Prepares For Future Use With OTTAVA Robotic PlatformFuture-Ready Surgical Energy Platform Designed For Flexibility, Precision And Robotic IntegrationDUALTO’s double-module option provides enhanced flexibility while cutting down on equipment clutter. Compared to traditional setups, the system reduces OR footprint by 46%, helping staff reclaim space and optimize surgical workflows.

    By Shubham Singh Verified · Citeline

    Apr. 16, 2025

As seen in

Company Info

Business Today (India)

Varanasi, Uttar Pradesh, India

+91 12 0480 7100